scispace - formally typeset
Search or ask a question
Institution

Charité

HealthcareBerlin, Germany
About: Charité is a healthcare organization based out in Berlin, Germany. It is known for research contribution in the topics: Population & Transplantation. The organization has 30624 authors who have published 64507 publications receiving 2437322 citations. The organization is also known as: Charite & Charité – University Medicine Berlin.


Papers
More filters
Journal ArticleDOI
TL;DR: It is demonstrated that bone marrow eosinophils localized together with plasma cells and were the key providers of plasma cell survival factors and depletion of eosInophils induced apoptosis in long-lived bone marrow plasma cells.
Abstract: Plasma cells are of crucial importance for long-term immune protection. It is thought that long-lived plasma cells survive in specialized niches in the bone marrow. Here we demonstrate that bone marrow eosinophils localized together with plasma cells and were the key providers of plasma cell survival factors. In vitro, eosinophils supported the survival of plasma cells by secreting the proliferation-inducing ligand APRIL and interleukin-6 (IL-6). In eosinophil-deficient mice, plasma cell numbers were much lower in the bone marrow both at steady state and after immunization. Reconstitution experiments showed that eosinophils were crucial for the retention of plasma cells in the bone marrow. Moreover, depletion of eosinophils induced apoptosis in long-lived bone marrow plasma cells. Our findings demonstrate that the long-term maintenance of plasma cells in the bone marrow requires eosinophils.

472 citations

Journal ArticleDOI
TL;DR: This prospective, randomized, multicenter study shows for the first time that somatostatin analogs, interferon alfa, or the combination of the two had comparable antiproliferative effects in the treatment of metastatic neuroendocrine gastroenteropancreatic tumors.
Abstract: Purpose: Somatostatin analogs and interferon alfa control hormone-active/functional neuroendocrine gastroenteropancreatic tumors. In addition to hormonal control, variable degrees of antiproliferative effects for both agents have been reported. Until now, however, no prospective, randomized studies in therapy-naive patients have compared somatostatin analogs or interferon alfa alone with a combination of the two. Methods: Eighty therapy-naive patients with histologically verified neuroendocrine tumor disease (primary localization: foregut, n = 36; midgut, n = 30; hindgut, n = 3; unknown, n = 11; functional, n = 29; nonfunctional, n = 51) were randomly treated either with lanreotide (1 mg three times a day administered subcutaneously [SC]) or interferon alfa (5 × 106 U three times a week SC) or both. All patients had disease progression in the 3 months before study entry, verified with imaging procedures. Results: Twenty-five patients were treated with lanreotide, 27 patients were treated with interferon a...

471 citations

Journal ArticleDOI
Padhraig Gormley, Verneri Anttila1, Verneri Anttila2, Bendik S. Winsvold3, Bendik S. Winsvold4, Priit Palta5, Tõnu Esko2, Tõnu Esko6, Tõnu Esko7, Tune H. Pers, Kai-How Farh8, Kai-How Farh1, Kai-How Farh2, Ester Cuenca-León, Mikko Muona, Nicholas A. Furlotte, Tobias Kurth9, Tobias Kurth10, Andres Ingason11, George McMahon12, Lannie Ligthart13, Gisela M. Terwindt14, Mikko Kallela15, Tobias Freilinger16, Tobias Freilinger17, Caroline Ran18, Scott G. Gordon19, Anine H. Stam14, Stacy Steinberg11, Guntram Borck20, Markku Koiranen21, Lydia Quaye22, Hieab H.H. Adams23, Terho Lehtimäki24, Antti-Pekka Sarin5, Juho Wedenoja5, David A. Hinds, Julie E. Buring10, Julie E. Buring1, Markus Schürks25, Paul M. Ridker1, Paul M. Ridker10, Maria Gudlaug Hrafnsdottir, Hreinn Stefansson11, Susan M. Ring12, Jouke-Jan Hottenga13, Brenda W.J.H. Penninx13, Markus Färkkilä15, Ville Artto15, Mari A. Kaunisto5, Salli Vepsäläinen15, Rainer Malik17, Andrew C. Heath26, Pamela A. F. Madden26, Nicholas G. Martin19, Grant W. Montgomery19, Mitja I. Kurki, Mart Kals7, Reedik Mägi7, Kalle Pärn7, Eija Hamalainen5, Hailiang Huang1, Hailiang Huang2, Andrea Byrnes2, Andrea Byrnes1, Lude Franke27, Jie Huang28, Evie Stergiakouli12, Phil Lee1, Phil Lee2, Cynthia Sandor29, Caleb Webber29, Zameel M. Cader29, Zameel M. Cader30, Bertram Müller-Myhsok31, Stefan Schreiber32, Thomas Meitinger33, Johan G. Eriksson5, Johan G. Eriksson34, Veikko Salomaa34, Kauko Heikkilä5, Elizabeth Loehrer23, Elizabeth Loehrer1, André G. Uitterlinden23, Albert Hofman23, Cornelia M. van Duijn23, Lynn Cherkas22, Linda M. Pedersen3, Audun Stubhaug3, Audun Stubhaug4, Christopher Sivert Nielsen35, Christopher Sivert Nielsen3, Minna Männikkö21, Evelin Mihailov7, Lili Milani7, Hartmut Göbel, Ann-Louise Esserlind36, Anne Francke Christensen36, Thomas Hansen36, Thomas Werge37, Thomas Werge38, Thomas Werge36, Jaakko Kaprio5, Jaakko Kaprio34, Arpo Aromaa34, Olli T. Raitakari39, Olli T. Raitakari40, M. Arfan Ikram23, Tim D. Spector22, Marjo-Riitta Järvelin, Andres Metspalu7, Christian Kubisch41, David P. Strachan42, Michel D. Ferrari14, Andrea Carmine Belin18, Martin Dichgans17, Maija Wessman5, Arn M. J. M. van den Maagdenberg14, John-Anker Zwart4, John-Anker Zwart3, Dorret I. Boomsma13, George Davey Smith12, Kari Stefansson43, Kari Stefansson11, Nicholas Eriksson, Mark J. Daly2, Mark J. Daly1, Benjamin M. Neale1, Benjamin M. Neale2, Jes Olesen36, Daniel I. Chasman1, Daniel I. Chasman10, Dale R. Nyholt44, Aarno Palotie 
TL;DR: For example, the authors identified 44 independent single-nucleotide polymorphisms (SNPs) significantly associated with migraine risk (P < 5 × 10−8) that mapped to 38 distinct genomic loci, including 28 loci not previously reported and a locus that to date is the first to be identified on chromosome X.
Abstract: Migraine is a debilitating neurological disorder affecting around one in seven people worldwide, but its molecular mechanisms remain poorly understood. There is some debate about whether migraine is a disease of vascular dysfunction or a result of neuronal dysfunction with secondary vascular changes. Genome-wide association (GWA) studies have thus far identified 13 independent loci associated with migraine. To identify new susceptibility loci, we carried out a genetic study of migraine on 59,674 affected subjects and 316,078 controls from 22 GWA studies. We identified 44 independent single-nucleotide polymorphisms (SNPs) significantly associated with migraine risk (P < 5 × 10−8) that mapped to 38 distinct genomic loci, including 28 loci not previously reported and a locus that to our knowledge is the first to be identified on chromosome X. In subsequent computational analyses, the identified loci showed enrichment for genes expressed in vascular and smooth muscle tissues, consistent with a predominant theory of migraine that highlights vascular etiologies.

471 citations

Journal ArticleDOI
Lavinia Paternoster1, Marie Standl, Johannes Waage2, H. Baurecht3  +151 moreInstitutions (55)
TL;DR: This paper performed a meta-analysis of >15 million genetic variants in 21,399 cases and 95,464 controls from populations of European, African, Japanese and Latino ancestry, followed by replication in 32,059 cases and 228,628 controls from 18 studies.
Abstract: Genetic association studies have identified 21 loci associated with atopic dermatitis risk predominantly in populations of European ancestry. To identify further susceptibility loci for this common, complex skin disease, we performed a meta-analysis of >15 million genetic variants in 21,399 cases and 95,464 controls from populations of European, African, Japanese and Latino ancestry, followed by replication in 32,059 cases and 228,628 controls from 18 studies. We identified ten new risk loci, bringing the total number of known atopic dermatitis risk loci to 31 (with new secondary signals at four of these loci). Notably, the new loci include candidate genes with roles in the regulation of innate host defenses and T cell function, underscoring the important contribution of (auto)immune mechanisms to atopic dermatitis pathogenesis.

471 citations

Journal ArticleDOI
TL;DR: By analysing the short non-responder questionnaires it was proven that the collected data give comprehensive and nationally representative evidence on the health status of children and adolescents aged 0 to 17 years.
Abstract: From May 2003 to May 2006, the Robert Koch Institute conducted the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Aim of this first nationwide interview and examination survey was to collect comprehensive data on the health status of children and adolescents aged 0 to 17 years. Participants were enrolled in two steps: first, 167 study locations (sample points) were chosen; second, subjects were randomly selected from the official registers of local residents. The survey involved questionnaires filled in by parents and parallel questionnaires for children aged 11 years and older, physical examinations and tests, and a computer assisted personal interview performed by study physicians. A wide range of blood and urine testing was carried out at central laboratories. A total of 17 641 children and adolescents were surveyed – 8985 boys and 8656 girls. The proportion of sample neutral drop-outs was 5.3%. The response rate was 66.6%. The response rate showed little variation between age groups and sexes, but marked variation between resident aliens and Germans, between inhabitants of cities with a population of 100 000 or more and sample points with fewer inhabitants, as well as between the old West German states and the former East German states. By analysing the short non-responder questionnaires it was proven that the collected data give comprehensive and nationally representative evidence on the health status of children and adolescents aged 0 to 17 years.

471 citations


Authors

Showing all 30787 results

NameH-indexPapersCitations
JoAnn E. Manson2701819258509
Yi Chen2174342293080
David J. Hunter2131836207050
Raymond J. Dolan196919138540
John P. A. Ioannidis1851311193612
Stefan Schreiber1781233138528
Kenneth C. Anderson1781138126072
Eric J. Nestler178748116947
Klaus Rajewsky15450488793
Charles B. Nemeroff14997990426
Andreas Pfeiffer1491756131080
Rinaldo Bellomo1471714120052
Jean Bousquet145128896769
Christopher Hill1441562128098
Holger J. Schünemann141810113169
Network Information
Related Institutions (5)
Ludwig Maximilian University of Munich
161.5K papers, 5.7M citations

93% related

Heidelberg University
119.1K papers, 4.6M citations

92% related

Johns Hopkins University School of Medicine
79.2K papers, 4.7M citations

92% related

Brigham and Women's Hospital
110.5K papers, 6.8M citations

92% related

Mayo Clinic
169.5K papers, 8.1M citations

92% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202339
2022317
20214,865
20204,577
20194,042
20183,718